Track: Cardio-Oncology

Cardio-Oncology is the branch of cardiology, is concerned with the early detection, continued monitoring, and therapeutic management of cardiovascular problems brought on by chemotherapeutic and radiotherapeutic side effects. Both cancer therapy options have the potential to cause cardiovascular dysfunction , a major cause of morbidity and mortality in the oncologic population. This field deals with the interaction of cardiologists, oncologists and other practitioners in order to provide complete care to a cancer patient including their cardiovascular health.

Cardiovascular Complications from Cancer Therapies:

Chemotherapy-Induced Cardiotoxicity: Certain medications, such as HER2 inhibitors (such as trastuzumab) and anthracyclines (such as doxorubicin), can result in heart failure and diminished left ventricular function.
Radiation-Induced Heart Disease: Arrhythmias, pericarditis, valvular heart disease, and coronary artery disease can all result from radiation therapy administered to the chest.
Immunotherapies and targeted therapies: Immuno check point inhibitors and tyrosine kinase inhibitors are examples of novel medicines that come with hazards like thrombosis, hypertension, and myocarditis.

Emerging Research and Future Directions:

Cardiovascular Toxicity of Cancer Therapies
Cardiac Imaging in Oncology Patients
Biomarkers for Cardiotoxicity
Cardiac Care During Cancer Treatment
Survivorship and Long-Term Cardiovascular Health
Cardiovascular Risk Assessment in Cancer Patients
Role of Cardio-Oncology Clinics
Advanced Imaging Techniques
Pharmacological Interventions
Personalized Medicine
Radiation-Induced Heart Disease
Targeted Therapies and Cardiovascular Effects
Role of Exercise and Rehabilitation
Cardiac Surgery in Oncology Patients
Cardiac Neoplasms
Fetal Heart Tumor

The Cardio-Oncology session will explore the intersection of cardiovascular health and cancer treatment, highlighting the latest research and clinical advancements in this rapidly evolving field. This session serves as a platform for sharing insights that address the complex challenges faced by both patients and clinicians. Abstract submission offers a meaningful opportunity to participate in and engage with this critical discourse to all those wishing to contribute. Participation in these discussions can significantly influence the future of cardio-oncology care.

3rd International Conference on Heart and Cardiovascular Diseases

Track: Cardio-Oncology

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at